News

Published on 23 Jan 2024 on Simply Wall St. via Yahoo Finance

With 39% stake, Foghorn Therapeutics Inc. (NASDAQ:FHTX) seems to have captured institutional...


Article preview image

Key Insights

Significantly high institutional ownership implies Foghorn Therapeutics' stock price is sensitive to their trading actionsA total of 4 investors have a majority stake in the company with 55% ownership Insider ownership in Foghorn Therapeutics is 12%

A look at the shareholders of Foghorn Therapeutics Inc. (NASDAQ:FHTX) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 39% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

NASDAQ.FHTX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insider Sale: Chief Scientific Officer Steven Bellon Sells 20,000 Shares of...

On September 9, 2024, Steven Bellon, Chief Scientific Officer of Foghorn Therapeutics Inc...

GuruFocus.com ยท via Yahoo Finance 21 Sep 2024

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Reported, And Analysts Assigned A US$11.67 Price Target

Last week, you might have seen that Foghorn Therapeutics Inc. (NASDAQ:FHTX) released its quarterl...

Simply Wall St. via Yahoo Finance 12 May 2024

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.59 per share versus the Zac...

Zacks via Yahoo Finance 6 May 2024

Wall Street Analysts Predict a 124.31% Upside in Foghorn Therapeutics Inc. (FHTX): Here's What You...

Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $6.54, gaining 5.1% over the ...

Zacks via Yahoo Finance 13 Mar 2024

Foghorn Therapeutics Inc. (FHTX) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Foghorn Therapeutics Inc. (FHTX), as it has been recently upgraded...

Zacks via Yahoo Finance 13 Mar 2024

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Tops Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.57 per share versus the Zac...

Zacks via Yahoo Finance 7 Mar 2024

Foghorn Therapeutics Inc. (FHTX) Moves 22.7% Higher: Will This Strength Last?

Foghorn Therapeutics Inc. (FHTX) shares ended the last trading session 22.7% higher at $5.95. The...

Zacks via Yahoo Finance 12 Feb 2024

With 39% stake, Foghorn Therapeutics Inc. (NASDAQ:FHTX) seems to have captured institutional...

Key Insights Significantly high institutional ownership implies Foghorn Therapeutics' stock price...

Simply Wall St. via Yahoo Finance 23 Jan 2024

Foghorn Therapeutics Inc. (FHTX) Upgraded to Buy: Here's Why

Investors might want to bet on Foghorn Therapeutics Inc. (FHTX), as it has been recently upgraded...

Zacks via Yahoo Finance 26 Dec 2023

Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Price Is Right But Growth Is Lacking After Shares Rocket...

Those holding Foghorn Therapeutics Inc. (NASDAQ:FHTX) shares would be relieved that the share pri...

Simply Wall St. via Yahoo Finance 1 Dec 2023